Fleroxacin: A New Once-a-Day Quinolone
- 1 March 1993
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 94 (3) , 1S
- https://doi.org/10.1016/s0002-9343(20)31132-3
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Comparative in-vitro activity of new quinolones against clinical isolates and resistant mutantsJournal of Antimicrobial Chemotherapy, 1992
- Cross-resistance and cross-susceptibility between fluoroquinolone agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- In-vitro activity of fleroxacin against urinary tract and genital tract pathogensJournal of Antimicrobial Chemotherapy, 1988
- In-vitro activity of fleroxacin compared with three other quinolonesJournal of Antimicrobial Chemotherapy, 1988
- Fleroxacin (Ro 23-6240): activity in virtro against 355 enteropathogenic and non-fermentative Gram-negative bacilli and Legionella pneumophilaJournal of Antimicrobial Chemotherapy, 1987
- Comparative in-virto activity of Ro 23-6240, a new trifluorinated quinoloneJournal of Antimicrobial Chemotherapy, 1987
- RO 23-6240 (AM-833), a new fluoroquinolone: In vitro antimicrobial activity and tentative disk diffusion interpretive criteriaDiagnostic Microbiology and Infectious Disease, 1987
- In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1986
- In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivativeAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of Ro 23-6240, a new fluorinated 4-quinoloneAntimicrobial Agents and Chemotherapy, 1986